M.D.C. - MDC Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View MDC analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month price targets for M.D.C.'s shares. Their MDC share price forecasts range from $27.00 to $28.00. On average, they expect the company's share price to reach $27.50 in the next twelve months. This suggests that the stock has a possible downside of 26.1%.
View analysts price targets for MDC or view top-rated stocks among Wall Street analysts.

M.D.C.'s stock was trading at $31.60 at the beginning of 2023. Since then, MDC stock has increased by 17.8% and is now trading at $37.23.
View the best growth stocks for 2023 here.

M.D.C. saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 2,510,000 shares, an increase of 15.7% from the January 31st total of 2,170,000 shares. Based on an average trading volume of 521,000 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.4% of the company's shares are short sold.
View M.D.C.'s Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our MDC earnings forecast.

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings data on Tuesday, January, 31st. The construction company reported $1.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.53 by $0.45. The construction company earned $1.49 billion during the quarter, compared to analysts' expectations of $1.31 billion. M.D.C. had a net margin of 9.83% and a trailing twelve-month return on equity of 19.24%. The business's quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the company earned $2.21 EPS.

M.D.C. declared a quarterly dividend on Monday, January 23rd. Investors of record on Wednesday, February 8th will be given a dividend of $0.50 per share on Wednesday, February 22nd. This represents a $2.00 dividend on an annualized basis and a yield of 5.37%. The ex-dividend date of this dividend is Tuesday, February 7th.
Read our dividend analysis for MDC.

ETFs with the largest weight of M.D.C. (NYSE:MDC) stock in their portfolio include Invesco Dynamic Building & Construction ETF (PKB), AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG), Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), Hoya Capital Housing ETF (HOMZ), Qraft AI-Enhanced Next Value ETF (NVQ), ETC 6 Meridian Small Cap Equity ETF (SIXS), Invesco S&P SmallCap 600 Pure Value ETF (RZV) and First Trust SMID Cap Rising Dividend Archievers ETF (SDVY).

M.D.C. (NYSE:MDC) pays an annual dividend of $2.00 per share and currently has a dividend yield of 5.45%. MDC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 26.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MDC will have a dividend payout ratio of 65.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDC.

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C.'s stock is owned by a number of retail and institutional investors. Top institutional shareholders include Moneta Group Investment Advisors LLC (11.48%), Dimensional Fund Advisors LP (7.01%), Hamlin Capital Management LLC (2.31%), Principal Financial Group Inc. (2.24%), Morgan Stanley (1.56%) and Geode Capital Management LLC (1.44%). Insiders that own company stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends.

Shares of MDC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDC stock can currently be purchased for approximately $37.23.

M.D.C. (NYSE:MDC) has a market capitalization of $2.72 billion and generates $5.72 billion in revenue each year. The construction company earns $562.14 million in net income (profit) each year or $7.67 on an earnings per share basis.

The company employs 1,643 workers across the globe.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The official website for the company is www.mdcholdings.com. The construction company can be reached via phone at (303) 773-1100, via email at ir@mdch.com, or via fax at 303-771-3461.